The weekly litigation news digest is live. Subscribe now

IP Verse

Compositions For Continuous Administration Of Dopa Decarboxylase Inhibitors - EP2432454

The patent EP2432454 was granted to Neuroderm on Mar 1, 2017. The application was filed on May 17, 2010 under application number EP10725880A. The patent is currently recorded with a legal status of "Opposition Rejected".

EP2432454

NEURODERM
Application Number
EP10725880A
Filing Date
May 17, 2010
Status
Opposition Rejected
Dec 6, 2019
Publication Date
Mar 1, 2017
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
TEVA PHARMACEUTICALSNov 29, 2017GREINERADMISSIBLE

Patent Citations (5) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
INTERNATIONAL-SEARCH-REPORTUS4409233
INTERNATIONAL-SEARCH-REPORTWO2006006929
OPPOSITIONUS4409233
OPPOSITIONWO2006006929
OPPOSITIONWO2010134074

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents